Brentuхіmab vedotin in the treatment of Hodgkin’s lymphoma
Summary. Brentuximab vedotin has been established as a highly effective drug that is included in the main treatment protocols of Hodgkin’s lymphoma. This article presents a list of studies that demonstrate the effectiveness of brentuximab vedotin both in monotherapy and in combination with different drugs for patients with relapsed/refractory Hodgkin’s lymphoma.
Leave a comment